Zyme Communications
We provide PR & marketing services for the life sciences sector: follow for the latest biotech news stories
@biocompare.bsky.social
Biocompare is a leading resource for up-to-date product information, product reviews, and new technologies for life scientists.
@faylinphd.bsky.social
Senior Technology Editor @ GEN Writing about AI x Bio ✉️ flin@genengnews.com
@vpd-hlri.bsky.social
University of Cambridge research institute aiming to improve cardiovascular and lung health for everyone, no matter where they live. www.hlri.cam.ac.uk
@mrcepid.bsky.social
Studying the genetic, developmental & environmental determinants of obesity, type 2 diabetes & related metabolic disorders. Contributing to their prevention.
@cambridgebrc.bsky.social
An @nihr.bsky.social partnership between @cuhnhs.bsky.social and the University of Cambridge @uniofcam.bsky.social We research different diseases to find new treatments & medicines. Based at CUH & Cambridge Biomedical Campus https://cambridgebrc.nihr.ac.uk
@cambcancer.bsky.social
We will build a new cancer research hospital to change the story of cancer. #ChangingTheStoryOfCancer
@cruk-ci.bsky.social
We are a world-leading cancer research institute dedicated to improving patient lives through discovery science. Core funded by Cancer Research UK, part of the University of Cambridge. www.cruk.cam.ac.uk
@mrclmb.bsky.social
The MRC Laboratory of Molecular Biology aims to understand biological processes at the molecular level to help tackle human health problems and disease.
@enhancedgenomics.bsky.social
At Enhanced Genomics, we are harnessing the full potential of the human genome to enhance drug discovery and personalised medicine. www.enhanc3dgenomics.com
@nature.com
Research, news, and commentary from Nature, the international science journal. For daily science news, get Nature Briefing: https://go.nature.com/get-Nature-Briefing
@natbiotech.nature.com
Publishing the best of biotech science and business. Part of @natureportfolio.bsky.social. Find us on Twitter, Facebook & Instagram.
@joachimeeckhout.bsky.social
Founder of Labiotech.eu and TheScienceMarketer.com | Mostly sharing biotech links (because I heard it's allowed here)
@genomeweb.bsky.social
Highlighting the best of GenomeWeb's coverage of the genomics sector. Read the latest news at genomeweb.com.
@firstwordgroup.com
FirstWord is a global leader in news and intelligence for the Pharma and MedTech industries. Find our services here www.firstwordpharma.com, www.firstwordhealthtech.com, and www.firstwordreports.com
@jonu235.bsky.social
$SRPT #Duchenne #Elevidys #GeneTherapy data which STATnews, Fierce Biotech, BiopharmaDIVE, and BioCentury REFUSE to report! https://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-announces-results-part-2-embark-study
@aylaellison.bsky.social
Editor-in-Chief, Fierce Biotech, Fierce Pharma, Fierce Healthcare
@megadarren.bsky.social
Science journalist and silly billy Staff writer at Fierce Biotech, other words in NYT, Science, Science News, etc. Inveterate invertebrate evangelist Opinions mine! Signal: dinc.49
@gabriellemasson.bsky.social
Senior Editor of Fierce Biotech | As read in Lily Poetry Review & Eunoia Review
@pharmaj.bsky.social
Established in 1841 as the RPS's official journal, The PJ is a trusted source of news, analysis, learning and research on pharmacy, medicines and pharmaceutical sciences https://pharmaceutical-journal.com https://pharmaceutical-journal.com/pj-app-faqs
@biocom.bsky.social
BIOCOM is synonymous with professional communication skills and a wide range of media for the life sciences. Content-driven and results-oriented since 1986.
@leileiwu.bsky.social
reporting on drugs and biotechs @endpoints • email me: lwu@endpointsnews.com • Signal: leileiwu.24 • ✌️
@nicoledefeudis.bsky.social
Biopharma reporter at Endpoints News | nicole@endpointsnews.com
@jaredwhitlock.bsky.social
features editor @endpts.com / fall 2021 fellow @ksjatmit.bsky.social Writing (and editing) stories on rare disease medicine, diagnostics and China Reach out privately on Signal: jaredwhitlock.73
@shelbylivingston.bsky.social
Reporter covering health tech for Endpoints News. Formerly Business Insider and Modern Healthcare. Charleston native, Clemson alum. Go Tigers!
@nicolewetsman.bsky.social
deputy editor @endpts.com // formerly the verge & abc news // soccer posts
@maxgelman.bsky.social
Reporting on pharma and biotech for Endpoints News. Baseball fan, Northwestern alum.
@maxbayer.bsky.social
Pharma reporter at Endpoints News | Past: Fierce Biotech and CBS News | mbayer@endpointsnews.com or chat me for Signal. he/him
@kylelahucik.bsky.social
reporting on the $, people & startups in the biotech world for Endpoints News | klahucik@endpointsnews.com | also coach high school XC + Track & Field team | askin Qs, joggin 26.2 | 🌎🏳️🌈🏃🏻♂️🗞️💨
@drewsnews.bsky.social
Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky Priors: Bloomberg News + the Covid vaccine tracker. CQ.
@andrewedunn.bsky.social
Reporter @ Endpoints News Covering biotech, pharma, AI, and more — the future of medicine adunn@endpointsnews.com
@endpts.com
We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com.
@dndi.org
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.
@rsc.org
With the future of the world in the balance, everyone has a role to play in making it better. How will you join in? 🌐 Website: www.rsc.org
@cenmag.bsky.social
https://cen.acs.org/ Sharing the world of #chemistry: News🗞 Research⚗️ Infographics #PeriodicGraphics ℹ Pictures #CENChemPics 📷 Comics #SketchChemistry 🗯 #FluorescenceFriday ❇️
@chemistryworld.com
Chemistry: Covered. The latest news, research, features and opinion from across the chemical sciences. Published by the Royal Society of Chemistry. https://www.chemistryworld.com/
@stuartcantrill.com
Husband, Dad, PhD, pedant, former Chief Ed of @natchem.nature.com, now Editorial Director at @NaturePortfolio.nature.com. Wine, chemistry, publishing, words & snark. Views ranty, but all mine. #ContaminatedBlood victim (affected). He/Him
@jakeyeston.bsky.social
Editor at Science Magazine, shepherding chemistry papers; views here are my own; he/him
@dereklowe.bsky.social
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. derekb.lowe@gmail.com and on Signal at Dblowe.18 All opinions are mine; I don’t speak for my employer in any way.
@laurahowes.bsky.social
Editor (she/her) @cenmag.bsky.social into biomolecules, drug discovery, and biotech. Also beer, skiing, and the joys of being an immigrant in Germany. All views expressed here are absolutely mine, especially when they're right. DM for Signal.
@holdenthorp.bsky.social
Editor-in-Chief of Science and Professor of Chemistry and Medicine at George Washington University. Opinions not those of AAAS. https://www.zotero.org/holdenthorp #ActuallyAutistic
@contractpharma.bsky.social
Our magazine, website and eNewsletters are devoted to providing important information about pharma and biopharma outsourcing. #contractpharma https://www.contractpharma.com/
@camrare.bsky.social
Making rare disease an everyday conversation. CamRARE is a charity empowering rare disease communities & fostering cross-sector collaboration to improve outcomes for those affected. #RareDisease Local | National | Global www.camraredisease.org
@cambridgeindy.bsky.social
Newsawards 2017, 2018, 2019, 2021, 2022 and 2023 - Weekly Newspaper of the Year, and 2024 News Brand of the Year, serving the Greater Cambridge community
@paulbrackleyci.bsky.social
Editor of the Cambridge Independent, senior group editor, East Anglia, at Iliffe Media